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Abstract
The transverse aortic constriction (TAC) model is frequently used to study adverse cardiac remodeling upon pressure overload. We
set out to define the most important characteristics that define the degree of cardiac remodeling in this model. A systematic review
and meta-analyses were performed on studies using the TAC mouse/rat model and reporting echocardiographic outcome param-
eters. We included all animal studies in which a constriction around the transverse aorta and at least one of the predefined
echocardiography or MRI outcome parameters were assessed. A total of 502 articles and > 3000 wild-type, untreated animals
undergoing TAC were included in this study and referenced to a control group. The duration of aortic constriction correlated to the
degree of adverse remodeling. However, the mouse data is strongly biased by the preferential use of male C57Bl/6 mice (66% of
studies). Furthermore, mostly ketamine/xylazine anesthetics, 27G needle constriction, and silk sutures are used. Nonetheless, despite
the homogeneity in experimental design, the model contained a substantial degree of heterogeneity in the functional outcome
measures. When looking at study quality, only 12% reported randomization, 23% mentioned any sort of blinding, 25% adequately
addressed the outcomes, and an amazingly low percentage (2%) showed sample size calculation. Meta-analyses did not detect
specific study characteristics that explained the heterogeneity in the reported outcomemeasures, however this might be related to the
strong bias towards the use of specific mouse lines, sex as well as age or to poor reporting of characteristics of study quality.
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Introduction
Approximately 23 million people worldwide suffer from heart
failure (HF), and this incidence will further increase the com-
ing decades. [1] The development of HF is characterized by a
process of adverse cardiac remodeling. [2] To study this pro-
cess, several animal models are available and a commonly
used model is a pressure overload–induced HF by transverse
aortic constriction (TAC). First described by Rockman et al in
1991, the TAC model was designed to study the mechanisms
behind cardiac hypertrophy. [3] Besides hypertrophy, the
model is characterized by cardiac fibrosis, a limited amount
of inflammation, and eventually cardiac dilation and HF. [4]
Animals subjected to TAC exhibit variable severity of adverse
cardiac remodeling [5], and multiple study characteristics can
potentially influence the response to TAC. Variability exists in
selected animal species, genetic background, sex, follow-up
time, and severity of constriction. To which extend these var-
iables affect the degree of cardiac remodeling is not known;
however, they are important for interpretation of published
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data and may aid to design optimization of the TAC model.
Since the introduction of murine echocardiography, numerous
studies using the TACmodel were published reporting cardiac
dimensions and function as outcome parameters. [6]
Translational failure is common in HF research; therapies
with efficacy in preclinical models have failedwhen applied to
human clinical trials. Multiple factors are involved in these
disappointing outcomes, including limitations in preclinical
animal models, hindering the development of new therapies
for HF. [7] Therefore, in this systematic review and meta-
analyses, we sought to evaluate the influence of animal char-
acteristics and methodological differences of TAC surgery on
echocardiographic outcome parameters. A systematic review
of animal studies using the TAC model may provide insight
into a number of issues currently impeding translation, such as
the characteristics of the animal model and the quality of the
published studies. Previously, systematic reviews of preclini-
cal studies have proven useful in design optimization of both
preclinical and clinical studies. [8] In this systematic review
and meta-analysis, we set out to analyze the influence of var-
iables such as strain, sex, and surgery characteristics on ad-
verse cardiac remodeling after TAC.
Methods
Search strategy
A detailed protocol was published online (PROSPERO regis-
tration number CRD42017079553; https://www.crd.york.ac.
uk/prospero/display_record.php?RecordID=79553) before
the start of this systematic review and provided as
supplement to this manuscript. [9] This systematic review is
based on published results of animal studies that used a
transverse aortic constriction (TAC) model in untreated,
wild-type animals to induce adverse cardiac remodeling.
Amendments to the review protocol
Data extraction was performed in duplicate by two individual
researchers for 57 (11.4%) randomly selected included stud-
ies, after which the percentage deviation between reviewers
was calculated. Since this percentage was very low, 0.8% for
numerical data and 1.2% for data extracted using digital ruler
software, data extraction for the remaining 443 studies was
performed by a single reviewer. We chose to leave the second-
ary outcome analysis because of the results of the primary
outcome analysis. Furthermore, we only took mouse for our
primary analysis because of limited number of articles for
other species and for the understandability of the mean differ-
ence instead of standardized mean difference.
Search and study selection
Pubmed and EMBASE were searched for transverse aortic
constriction and its synonyms on 12-04-2017 (see
supplemental table 1&2 for all search terms). A second search
was done on 20-03-2019, to update this review. The animal
filters developed by SYRCLE were used to select only animal
studies. [10] Duplicates were removed in Endnote.We includ-
ed all animal studies in which TAC surgery was performed,
with a constriction around the transverse aorta between the
brachiocephalic artery and left common carotid artery, and at
least one of the following outcome parameters assessed by
echocardiography or MRI were included: end diastolic vol-
ume (EDV) or end diastolic diameter (EDD), end systolic
volume (ESV) or end systolic diameter (ESD), and/or ejection
fraction (EF) or fractional shortening (FS). All animal species
and sexes were included. Only studies with a relevant control
group (sham surgery, baselinemeasurements or untreated con-
trol animals) were included. Only full publications with orig-
inal data were included. All studies without TAC or the func-
tional outcome parameters mentioned above were excluded.
Animals with comorbidities, genetically modified animals,
animals undergoing co-intervention such as compound or sol-
vent administration were excluded. Abdominal, ascending,
and descending aortic constriction, angiotensin II infusion,
and other ways of inducing hypertension/pressure overload
were excluded. Conference abstracts, letters to the editor,
and editorials were excluded. Articles not reporting the num-
ber of animals were excluded. The systematic review platform
SyRF (syrf.org.uk) was used for study selection and extraction
of data. Articles were first screened for eligibility based on
their title and abstract, and eligible articles were then
screened for final inclusion based on full text. Title/abstract
screening and full-text screening were performed by at least
two independent researchers, and discrepancies were addi-
tionally assessed by a third investigator.
Data collection
From each publication, the following data was extracted: spe-
cies, genetic background, sex, age, weight, number of ani-
mals, TAC duration, characteristics of TAC procedure namely
suture material, constriction diameter, anesthetic, follow-up
time, and whether a minimally invasive surgery technique
was used defined as entering the thorax through the 2nd inter-
costal space. When articles reported a range of, for instance,
age or weight, the average was taken. Outcome data were
extracted for the primary outcomes EDD, EDV, ESD, and
ESVand the secondary outcomes FS and EF by echocardiog-
raphy or MRI, cardiac hypertrophy, and survival. For each
outcome, group averages, standard deviation (SD), and num-
ber of animals per group (n) were extracted. If the standard
error was reported, it was converted to SD. When multiple
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time points were assessed, only data from the latest time point
was extracted. When data was presented only graphically, a
digital ruler was used for extraction (Universal Desktop Ruler;
AVPSOFT).
Risk of bias assessment
To assess risk of bias, SYRCE’s Risk of Bias tool was used
[11] with some adaptations. We included reporting of sample
size calculations as an additional study quality indicator. In
addition, we extracted data on the reporting of any measure
of randomization, blinding, or conflict of interest statement.
Furthermore, we assessed if outcome data were adequately
addressed, defined by reporting the number of animals includ-
ed in the analysis separately for each outcome measure.
Data synthesis and statistical analysis
Data were analyzed using STATA/SE, (version 11; StataCorp,
College Station, TX, USA). For EDD, EDV ND ESD, and
ESV, we calculated the effect size as mean difference (MD)
between the TAC group and non-TAC control group
(consisting of a mixture of nontreated and sham controls) with
corresponding 95% confidence interval (MD [95%CI]). To
account for anticipated heterogeneity, effect sizes were pooled
using random effects meta-analysis, taking into account the
precision of individual studies and the variation between stud-
ies and weighing each study accordingly. Heterogeneity was
quantified using I2 and R2 statistics. Pre-specified subgroup
analyses were performed using meta-regression if at least two
subgroups contained ≥ 5 comparisons. If meta-regression in-
dicated that a subgroup variable explained a significant pro-
portion of between-study heterogeneity, differences between
individual strata were determined by performing a t test on the
MD or RR and 95% CI of these strata.
Results
Study selection process
After removal of duplicates, a total of 7742 papers were in-
cluded, after which 3226 articles were excluded (flow chart in
Fig. 1) based on title and abstract. During full-text screening,
3351 articles were further excluded, see Fig. 1 for the number
of articles excluded per exclusion criterion. A total of 468
articles were used for data extraction.
Animal characteristics
The 464 included articles contained a total of 500 comparisons
of an experimental group exposed to TAC versus a group
measured at baseline or undergoing sham surgery. All
included experiments were performed in rodents, of which
95% (472/500 comparisons) in mice and 5% (28/500) in rats.
Data were predominantly obtained from male animals (66%,
332/500). Females were used in 5% (21/500) of comparisons,
8% (45/500) used a mixed group of animals, and 21% (102/
500) did not report the sex of the animals used (Fig. 2a).
Various different mouse strains were used (Fig. 2b). Most
commonly C57BL/6 mice (67%, 344/472), for 10% (46/
472) of the comparisons, the mouse strain was not specified.
Median age of the mice was 10 weeks, ranging from 3 to
56 weeks, and 7 weeks for rats (range: 3–12 weeks). The
median body weight was 25 g for mice (range: 20–36 g) and
155 g for rats (range: 45–250 g).
Surgery characteristics
As the vast majority of studies was performed in mice and in
order to improve clarity and readability of the manuscript, we
decided to continue further on sub analysis in mouse studies
only. For TAC or sham surgery, mainly ketamine and xylazine
(≈40%, 191/500) or isoflurane (≈30%, 171/500) were used as
anesthetic (Fig. 3a). Thirty-five percent of the experiments
were performed using minimally invasive techniques, 32%
was not performed minimally invasively, and 33% did not
specify this (respectively 174, 162, and 164 out of 500 com-
parisons). The most frequently used technique to apply TAC
was placing a suture around the transverse aorta (80%, 400/
500). Of the studies reporting suture type, 53% (204/383 com-
parisons) used a silk suture (Fig. 3b), while 25% (95/383)
made use of polyamide and 12% (47/383) of a prolene suture.
In 4% (20/500) of the comparisons, a clip was used to apply
TAC, and 16% (80/500) did not mention the material or meth-
od used for TAC induction. The TAC diameter was reported in
373/500 comparisons in gauge (G) of the needle used, which
ranged from 17 to 30G. In most cases, a 27G needle was used
(71%; 265/373), followed by 26G (12%; 45/373) and 25G
(7%; 26/373). In 33% of cases (154/500), confirmation of
TAC after surgery was reported, which was performed by
echo/doppler in 122 of these comparisons and in 42 by inva-
sive pressure measurements. In 66% (336/500) of the studies,
either confirmation of pressure overload on the heart was not
assessed or it was not reported (Fig. 3c). After surgery, follow-
up time ranged from 3 to 280 days. Most experiments used a
follow-up time of 28 days (21%; 107/500), followed by 14
and 56 days (both 10%; 53/500) and 7 days (6%; 32/500). For
functional outcome assessment, most comparisons (96%; 387/
500) used 2D echocardiography. In a small proportion of the
studies (3%, 13/500 comparisons), MRI was used.
Study quality assessment
The overall reporting of study quality indicators is presented
in Fig. 4. Out of the total of 464 included studies, 342 (74%)
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included a conflict of interest statement, of which the vast
majority (325, 95%) stated to have no conflict of interest.
Only 23% (n = 108) studies reported the number of animals
included in the analysis separately for each outcome measure
(depicted as outcome data adequately addressed). Therefore, it
cannot be ruled out that the majority of studies have excluded
a number of animals for some of the outcome assessments.
Unfortunately, the (predefined) criteria for exclusion were not
reported. A limited number of studies reported randomization
of animals (12%) or blinding (23%) of the investigators during
the study at any level (allocation of the animals, blinding of
researchers performing the experiment, or blinding during
follow-up analysis). Only 11 studies (2%) reported a sample
size calculation. Taken together, these data implicate a sub-
stantial risk of bias in the majority of published articles using
the TAC model.
Meta-analysis
Despite the substantial risk of bias and the preference for
using male C57Bl/6 mice, we investigate what the differ-
ences are in response to pressure overload between the
sexes and different mouse strains. With these data in hand,
we aim to aid to validated decision making regarding the
choice for a specific animal model, strain, and sex. TAC
induces severe structural remodeling of the heart, and we
defined end diastolic (end diastolic diameter (EDD) and
volume (EDV)) and end systolic diameter (ESD) and vol-
ume (ESV)) function as primary outcome measures. In a
total of 341 comparisons with 3370 mice subjected to
TAC, we observed an increase in EDD of 0.35 mm [0.3–
0.4; I2 91.2% p < 0.0001, Fig. 5a] compared with 2984
control mice. Total 398 mice subjected to TAC displayed
Fig. 1 Flow chart of study
selection process. Our systematic
search in Pubmed and EMBASE
yielded 7742 unique publications.
After title and abstract screening,
articles were screened full text of
which 4355 were excluded based
on exclusion criteria. Data from
464 articles was included in meta-
analysis and quality assessment.
TAC transverse aortic constric-
tion, admin administration, other
possible reasons: additional sur-
gery such as ovariectomy,
methods not mentioned clearly,
for instance duration of TAC not
stated, NR not reported
Fig. 2 Distribution of sex and mouse strain. Distribution of a sex of the animals in all included studies and b mouse strains of included mouse studies
(absolute numbers of a total of 500)
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an average EDV increase of 20.09 μl [15.7–24.4; I2 92.8%
p < 0.0001, Fig. 5b] compared with 356 control mice from
a total of 39 studies/comparisons. When assessing systolic
function, ESD increased with 0.50 mm [0.43–0.58; I2
16.0% p = 0.017, Fig. 5c] in 2615 mice subjected to TAC
referenced to 2383 control mice derived from 270 studies.
Based on 35 studies ESV was on average increased by
28.74 μl [20.8–36.68; I2 99.9% p < 0.0001, Fig. 5d] based
on 345 mice subjected to TAC compared with 299 control
mice.
Fig. 3 Study characteristics. Distribution of a anesthetics used during TAC or sham surgery, b surgical technique, c degree of constriction, d
confirmation of pressure overload, and e method of constriction and suture materials (absolute numbers of a total of 500)
Fig. 4 Data quality. Reporting of
study quality indicators; conflict
of interest statement, outcome
data adequately addressed,
blinding, randomization, and
sample size calculation in the 464
included articles
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Subgroup analysis
Subgroup analyses were performed to identify sources of
between-study heterogeneity. Table 1 summarizes the influ-
ence of the following study characteristics on the level of
heterogeneity: sex, strain, and confirmation of the TAC.
None of the investigated variables explained a significant pro-
portion of the heterogeneity present in the overall analysis.
Due to low number of comparisons for ESV/EDV, we did
not investigated heterogeneity in these outcome parameters.
Influence of sex and strain on TAC model
TAC surgery was effective in both sexes and did not differ
depending on the sex of the animals (male versus female ver-
sus mixed versus not known) for any of the outcome measures
(Fig. 6 a and b show the influence of sex on EDD and ESD,
respectively). The strain of the mouse also did not account for
a significant proportion of the heterogeneity in the overall
analysis. The major differences are observed between
C57Bl/6 and Balb/C mice; however, it must be noted that
these outcomes may be biased as a consequence of the large
proportion of studies that used C57BL/6, while only very
limited numbers used Balb/c mice. In Fig. 6 c and d, the effect
of mouse strain on EDD and ESD (MD) is shown. Also con-
firmation of proper placement of the TAC and thus cardiac
pressure overload did not affect EDD and ESD (Fig. 6e, f).
Influence of duration and diameter of constriction
on TAC severity
The duration of constriction varied from 3 to 280 days after
TAC placement. Linear regression showed borderline signifi-
cance for the effect of TAC duration on the primary outcome
EDD (p = 0.061, Fig. 7a), while a stronger effect of constric-
tion duration on the ESD was observed (p = 0.001, Fig. 7b).
The constriction diameter of the needle used to apply the TAC
varied from 17 to 30G. However, most data clustered around
27G. Linear regression did not show a significant relation
between constriction diameter and EDD (p = 0.117) or ESD
(p = 0.088, data not shown).
Fig. 5 TAC induces severe structural remodeling of the heart. Forest plots
of the effect of TAC on a end diastolic diameter (EDD; n = 314
comparisons), b end diastolic volume (EDV; n = 39), c end systolic
diameter (ESD; n = 270), and d end systolic volume (ESV; n = 35).
Data are presented as raw mean difference (MD) and 95% confidence
intervals (95%CI). In all analyses, the pooledMD and 95%CI (horizontal
dotted line and black line) indicate an increase outcome after TAC, when
compared with controls
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Discussion
This systematic review and meta-analyses provide an over-
view of the commonly used animal model to study adverse
cardiac remodeling: transverse aortic constriction (TAC). As
expected, TAC significantly increased the EDD, EDV, ESD,
and ESV indicative of adverse cardiac remodeling and heart
failure.
Animal characteristics
A clear preference for certain animal characteristics was seen.
First, only rodents (mice and rats) were included in our study.
During the screening phase, we noticed that in large animals
(such as pigs and dogs), only a constriction of the ascending or
descending aorta is used. Therefore, these animal species were
not included in our review. Second, most of the articles used
male animals, a very little proportion of studies was performed
in female animals only. A troublesome 21% failed to report
the sex of the animals. This sex bias, which is widespread in
clinical and preclinical studies, is reason for concern. [12]
Previously, a systematic review showed that the sex of the
animals used was not reported in 20% of published cardiovas-
cular animal research. Males were exclusively used in the
majority (72%) of studies, whereas only 13% of articles re-
ported the use of female animals. [13] These numbers are
similar to our findings in for TAC model. In subgroup
analysis, we were not able to show any effects of sex on the
outcome parameters. Clinical studies document that female
patients with similar degree of aortic stenosis more frequently
demonstrate thick-walled chambers, corresponding with con-
centric left ventricular hypertrophy, compared with male pa-
tients. [14, 15] However, in preclinical studies, the
distinguishing between concentric and eccentric hypertrophy
is rarely made. Regarding mouse strain, a clear preference is
seen for C57BL/6, used in 73% of the included mouse studies.
A previous study showed that even the specific substrains of
C57BL/6 differ in their (hypertrophic) response to TAC, indi-
cating that genetic background might be of influence on the
cardiac outcome after TAC. [16] However, in our subgroup
analysis, no statistical significant proportion of between-study
heterogeneity could be attributed to mouse strain for any out-
come measure. However, this may be due to limited data
available for certain strains or a lack of reporting on the spe-
cific C57BL/6 substrain used.
Surgery characteristics
The standard surgery procedure in TACmodels is to perform a
partial thoracotomy for visualization of the aortic arch. This
open-chest model leads to changes in respiratory physiology
caused by the thoracotomy. To prevent this, a minimally inva-
sive surgical technique through the 2nd intercostal space was
developed, leading to a more rapid recovery of the mice. [17]
Table 1 Influence of: sex, strain, and confirmation of the TAC on the level of heterogeneity in EDD and ESD
EDD ESD
# MD (mm) [95%CI] # MD (mm) [95%CI]
Sex p = 0.41, adj. R2 = − 0.44% p = 0.85 adj. R2 = − 3.38%
Female 13 0.26 − 0.02, 0.55 8 0.58 0.13, 1.04
Male 217 0.38 0.31, 0.45 179 0.53 0.43, 0.62
Mixed 36 0.35 0.18, 0.53 24 0.48 0.24, 0.73
Not reported 75 0.27 0.15, 0.39 59 0.45 0.29, 0.61
Mouse strain p = 0.04, adj. R2 = 2.84% p = 0.11 adj. R2 = 5.51%
129 15 0.14 − 0.12, 0.39 14 0.45 0.29, 0.61
Balb/c 2 − 0.23 − 1.05, 0.60 3 0.53 0.43, 0.62
C57BL/6 250 0.40 0.34, 0.47 194 0.53 0.43, 0.62
FVB 22 0.11 − 0.11, 0.32 15 0.58 0.13, 1.04
Mixed 7 0.10 − 0.33, 0.52 6 0.53 0.43, 0.62
Other 12 0.21 − 0.08, 0.50 12 0.53 0.43, 0.62
Swiss 3 − 0.03 − 0.61, 0.55 3 0.45 0.29, 0.61
Not reported 30 0.21 0.20, 0.58 23 0.45 0.29, 0.61
TAC confirmed p = 0.63, adj. R2 = − 0.36% p = 0.66 adj. R2 = − 1.52%
Echo/doppler 85 0.34 0.22, 0.45 63 0.51 0.35, 0.68
Invasive pressure 33 0.27 0.10, 0.45 29 0.40 0.17, 0.64
Not reported 223 0.37 0.30, 0.43 178 0.52 0.42, 0.62
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Fig. 6 Influence of sex, mouse
strain, and confirmation of
pressure overload on end diastolic
and end systolic diameters. Effect
of sex (a), mouse strain (b), and
confirmation of pressure overload
on the outcome parameters EDD
and ESD (MD). Horizontal dotted
and solid lines represent pooled
effect and its 95% confidence
interval. In each bar, the number
of comparisons contributing data
is indicated
Fig. 7 Correlation between
duration of TAC and end diastolic
and end systolic diameters. Effect
of duration on TAC on EDD (a)
and ESD (b) increase. Graph
depicts mean difference in EDD
and ESD for each individual
comparison. p value derived from
linear regression analysis
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Minimal invasive surgery was performed in 35% of the in-
cluded studies. After surgery, 34% of studies mentioned con-
firmation of the TAC by either echo or invasive pressure mea-
surements. This means that a relatively large proportion of
studies may not have confirmed the constriction. Doppler
echocardiography is a relatively easy and noninvasive tech-
nique to assess TAC severity without compromising future
vascular access. [5] From our own experience, we know that
sometimes a suture loosens, preventing adverse cardiac re-
modeling from happening. The low percentage of TAC con-
firmation might explain why a proportion of studies showed
no or only very little adverse remodeling.
The majority of studies (71%) made use of 27G needles for
TAC placement. No association between needle size and the
outcome parameters was however observed. This is possibly
due to clustering of data points around 27G since relatively
large or small needles were less frequently used. Interestingly,
only a marginal significant effect of TAC duration on one
outcome parameter (EDD) was present. This was unexpected
since a longer duration of TAC would generally lead to in-
creased adverse remodeling and changes in all outcomes.
Absence of association there might point towards inconsisten-
cy of the model causing large variability between animals and
studies.
Effect of TAC on the outcome parameters
When compared with control animals, TAC results in an in-
crease in cardiac diameters and volumes (EDD, EDV, ESD,
and ESV). Mice subjected to TAC exhibit variable severity of
adverse remodeling. It was previously shown that independent
of study characteristics, such as sex, strain, needle size, or time
course, considerable variability exists within the model even
when performed at the same laboratory. [5] Part of the animals
show compensated LV hypertrophy, while only a subset of
animals develop overt HF. Understanding this variability in-
volved in the model is crucial to appropriate study design and
interpretation, particularly when effects of conditional expres-
sion of genetic interventions or pharmacologic agents are
studied. Variability within the model will affect the sample
size required to detect the effect of treatment or genetic alter-
ations. Of the included studies, 16–17% used ≤ 5 animals in
the TAC group, and since only 7 out of 371 studies reported a
power calculation, reproducibility of these results might be of
concern [5]. The original Rockman technique [3] induces an
identical flow area for each animal, regardless of its habitus,
consequently causing a variable degree of aortic constriction.
This leads to a greater pressure overload on the LV in heavier
animals compared with smaller ones. Adjusting the constric-
tion to the size of the mouse and the aorta can lead to more
homogeneity of the results. [18] In our sub-analysis, we did
not observe a significant influence of the average weight in
each study. However, individual differences between mice per
study are likely to exist.
Study quality
Seventy-four percent of included papers mentioned a conflict
of interest statement, of which most reported no conflicts of
interest. Unfortunately, the other study quality indicators were
very poorly reported. Only 23% reported blinding of the in-
vestigator during the study at any level, and only 10 studies
reported a sample size calculation. Most articles did not report
the number of animals used for each outcome measure.
Adequate reporting of these methodological details is crucial
to determine the risk of bias and to assess the quality of the
evidence. [19]When the TACmodel is used to study effects of
treatment on adverse remodeling, underreporting of research
methodology is often associated with an overestimation of
effects. [20] As previously mentioned, we noticed that the
number of animals in some studies was very low, and this
might contribute to translational failure of preclinical studies.
Since most of the studies did not include a power calculation,
we cannot exclude the possible effect of under powering on
our meta-analysis.
Limitations of this review
Twenty-three studies were excluded because no animal num-
bers were reported. Furthermore, we had to exclude various
articles because we could not confirm whether TAC was per-
formed or another type of aortic banding. Both reasons indi-
cate also low quality of methodological reporting and increase
the risk of bias. However, because we excluded these papers,
we cannot state this with certainty. In our search, we used for
our control group both sham-operated animals as not-operated
animals. This could have caused variation in our data, which
we did not take into account. Data extraction was mainly
performed by one reviewer, but because of the small
between-reviewer deviations observed in the random sample,
the effect is likely to be small. A full risk of bias assessment
was not yet performed, and the very high amount of hetero-
geneity remains unexplained.
Conclusion
The general TAC study is performed using a similar set-up as
originally described by Rockman et al. [3], using male
C57BL/6 mice of 10 weeks old with ketamine and xylazine
as anesthetic, tightening the constriction around a 27G needle
using a silk suture. Follow-up time is generally 28 days, and
echocardiographic outcome parameters are assessed using 2D
echocardiography. The murine TAC model is a very valuable
but also variable animal model. For the future, especially
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when the TACmodel is used to test pharmacological interven-
tions, it is imperative that adequate numbers of mice are used,
both sexes are studied, and the severity of constriction is con-
firmed after TAC or new operation techniques are applied to
limit variability within the model.
.
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